Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies

Enhancer of zeste homolog 2 (EZH2), an enzymatic subunit of PRC2 complex, plays an important role in tumor development and progression through its catalytic and noncatalytic activities. Overexpression or gain-of-function mutations of EZH2 have been significantly associated with tumor cell proliferat...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Husheng, Wu, Hong, Yang, Jing, Zhou, Bin, Wang, Aoli, Hu, Chen, Qi, Shuang, Jiang, Zongru, Zou, Fengming, Wang, Beilei, Liu, Feiyang, Chen, Yongfei, Wang, Wenchao, Liu, Jing, Liu, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841011/
https://www.ncbi.nlm.nih.gov/pubmed/36642705
http://dx.doi.org/10.1038/s41392-022-01240-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9841011/
https://www.ncbi.nlm.nih.gov/pubmed/36642705
http://dx.doi.org/10.1038/s41392-022-01240-3

Ejemplares similares